Showing 481-490 of 596 results for "".
New Drugs in Psoriasis
https://practicaldermatology.com/topics/psoriasis/new-drugs-in-psoriasis/20933/The last two years have seen a number of new drugs approved to treat psoriasis—from targeted biologics to new topicals.How to Integrate Physician-Dispensed Products
https://practicaldermatology.com/topics/general-topics/PD0609_10-php/22819/With the correct protocols, staff training, and product selection, physician dispensing can help retain your current patient base and assist in marketing to new patients.Exosomes: The Next Big Thing in Skincare?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/exosomes-the-next-big-thing-in-skincare/23684/There is still a lot to learn, but early evidence suggests that topically applied exosomes may transform the approach to skincare.• Cosmetic Eyeliner Tattoo Complications
• Morphea After Endovenous Cyanoacrylate Adhesive Embolizationhttps://practicaldermatology.com/youngmd-connect/resident-resource-center/bull-cosmetic-eyeliner-tattoo-complicationsbrbull-morphea-after-endovenous-cyanoacrylate-adhesive-embolization/23771/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/23510/Update: Biomarkers for Guiding Treatment in Early Stage Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-biomarkers-for-guiding-treatment-in-early-stage-melanoma/23260/A look at current tools for risk stratification of melanoma, controversy surrounding SLNB for staging, and novel adjuvant immunotherapies for early stage disease.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20671/New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21573/Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Lupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.